Clinical Trial Update: Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial on berberine hydrochloride and bifidobacterium for prediabetes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes

Drugs mentioned

• Berberine hydrochloride (berberine hydrochloride)
• Bifidobacterium (Bifidobacterium)

Snippet

Sponsor: Xijing Hospital | Conditions: Prediabetes | Phase 2, Phase 3 | Status: WITHDRAWN